LFA: The Mysterious Paper-Based Biosensor: A Futuristic Overview

Lateral flow assay (LFA) is emerging as one of the most popular paper-based biosensors in field diagnostic industry. LFA fills all gaps between diagnosis and treatment it provides beneficial qualities to users such quick response, Point-of-care appeal, early detection, low cost, effective sensitive detections various infectious diseases. These benefits increase LFA’s dependability for disease management because rapid accurate a prerequisite medication. Only 2% overall healthcare expenditures, according Roche Molecular Diagnostics, are spent on vitro diagnostics, even though 60% choices based this data. To make more innovative, futuristic plans have been outlined many reports. Thus, review reports very knowledgeable literature discussing its development along with recent LFA-based that cover novel features improvement LFA. might therefore pose significant economic success influence medical diagnosis.